Coherus Oncology Inc (CHRS)

Investing Cash Flow

$60.29M

Quarterly · Period ending: · USD

CHRS logo

CHRS Investing Cash Flow

Latest reported$60.29M
CHRS Quarterly Cash from Investing (-$168.00K → $60.29M)
High-resolution chart · PNG

CHRS investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
60,286,000
30,655,000
-2,838,000
-67,227,000
462,638,000
-17,486,000
-542,000
444,000
27,656,000
202,763,000
35,203,000
50,546,000
41,365,000
17,526,000
-129,898,000
-457,000
-880,000
-35,615,000
107,490,000
15,990,000
23,585,000
-285,475,000
210,056,000
16,407,000
-239,248,000
-1,616,000
-6,062,000
-289,000
8,818,000
-15,199,000
15,786,000
12,811,000
-16,604,000
-13,181,000
14,391,000
28,706,000
4,064,000
-51,578,000
-3,566,000
-500,000
-301,000
-2,148,000
-1,444,000
-3,184,000
-1,008,000
-1,313,000
-499,000
-807,000
-1,293,000
2,074,000
-148,000
-53,000
-4,000
-168,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.